In development: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Expected publication date

Expected publication date

Area of interest

Area of interest

Type 1 selected

Type

Guidance programme

Showing 76 to 100 of 374

TitleTypeExpected publication date
Datopotamab deruxtecan for previously treated hormone receptor-positive HER2-negative unresectable or metastatic breast cancer [ID6348]Technology appraisal guidanceTBC
DCVax-L for treating glioblastoma [ID836]Technology appraisal guidanceTBC
Decitabine–cedazuridine with venetoclax for untreated acute myeloid leukaemia when intensive induction chemotherapy is unsuitable [ID6601]Technology appraisal guidance
Degarelix before or with radiotherapy for treating high-risk localised and locally advanced hormone-dependent prostate cancer [ID6419]Technology appraisal guidanceTBC
Denecimig (Mim8) for preventing bleeding episodes in haemophilia A in people of any age [ID6400]Technology appraisal guidance
Depemokimab for treating severe eosinophilic asthma in people 12 years and over [ID6447]Technology appraisal guidanceTBC
Deuruxolitinib for treating severe alopecia areata [ID6597]Technology appraisal guidance
Deutetrabenazine for treating tardive dyskinesia [ID6550]Technology appraisal guidanceTBC
Dexmedetomidine for treating agitation associated with bipolar disorder in people 18 to 75 years [TSID10725]Technology appraisal guidanceTBC
Dexmedetomidine for treating agitation associated with schizophrenia [TSID10726]Technology appraisal guidanceTBC
Diabetes in pregnancy: management from preconception to the postnatal period - Managing type 1 diabetes (T1D) using hybrid closed loops (update)NICE guideline
Digital platforms to support rehabilitation before and after primary elective hip or knee replacement surgeryHealth technology evaluation
Digital technologies delivering CBT for insomnia in adultsHealth technology evaluation
Digital technologies for applying algorithms to spirometry to support asthma and COPD diagnosis in primary care and community diagnostic centres: early-use assessmentHealth technology evaluation
Digital technologies for multidisciplinary weight managementHealth technology evaluationTBC
Digital technologies for the early detection and initial diagnosis of adult hearing loss (provisional title)HealthTech guidanceTBC
Digital technologies to support monitoring of vision change at home for people with age-related macular degeneration: early use assessmentHealth technology evaluation
Digital technologies to support self-management of asthma: early value assessmentHealth technology evaluation
Digital technologies to support smoking cessation in secondary care patients: early value assessmentHealth technology evaluationTBC
Domestic AbuseNICE guideline
Domvanalimab with zimberelimab for untreated unresectable advanced gastric, gastro-oesophageal junction or oesophageal cancer [ID6606]Technology appraisal guidanceTBC
Donanemab for treating mild cognitive impairment or mild dementia caused by Alzheimer's disease [ID6222]Technology appraisal guidanceTBC
Donidalorsen for preventing recurrent attacks of hereditary angioedema in people 12 years and over [ID6457]Technology appraisal guidance
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiency (MA review of TA779) [ID6326]Technology appraisal guidance
Dostarlimab with chemotherapy for untreated and with niraparib for maintenance treatment of advanced non-mucinous epithelial ovarian, fallopian tube or primary peritoneal cancer [ID6311]Technology appraisal guidanceTBC

Results per page

  1. 10
  2. 25
  3. 50
  4. All